Lacay, Vevelyn .
HRN: 18-01-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFUROXIME 500MG (TAB)
08/30/2023
09/07/2023
PO
500mg
BID
Rmle
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes